Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsSUBLINGUALGeneric

SORBITRATE

ISOSORBIDE DINITRATE

Standard Dose
5MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview SORBITRATE is listed in Drugs@FDA under application 016191 (NDA).

Marketing status: Discontinued Active ingredient ISOSORBIDE DINITRATE Form and strength TABLET;SUBLINGUAL - 5MG Sponsor ASTRAZENECA Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview SORBITRATE is listed in Drugs@FDA under application 016191 (NDA). Marketing status: Discontinued Active ingredient ISOSORBIDE DINITRATE Form and strength TABLET;SUBLINGUAL - 5MG Sponsor ASTRAZENECA Submission history See approval history documents.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.